IVZ vs ZION
Invesco vs Zions Bancorporation — AI-powered side-by-side comparison
VS
ZION
Zions Bancorporation
67
Buy
| Metric | IVZ | ZION |
|---|
| AI Score |
67
|
67
|
| Price |
$32.71
|
$67.56
|
| P/E Ratio |
-47.72×
|
8.62×
|
| ROE |
-2.3%
|
12.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
67.4%
|
71.4%
|
| Debt / Equity |
0.13×
|
0.41×
|
| Dividend Yield |
2.6%
|
2.7%
|
| RSI (14) |
62.0
|
29.2
|
| Beta |
1.596
|
0.781
|
| Expected Upside |
—
|
+0.5%
|
AI Committee View
Current Innellis committee reasoning for IVZ versus ZION.
The committee scores are tied.
IVZ and ZION both score 67/100.
IVZ Committee View
80% agreement
5 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical
- Bollinger bandwidth of 16.1% signals elevated volatility — Risk
ZION Committee View
60% agreement
5 analysts
The primary driver is revenue growing 53.6% yoy -- genuine top-line momentum. The main limiting factor is macd histogram negative -- bearish momentum. The committee is constructive but not yet at full conviction.
Bull Case
- P/E of 8.9 is inexpensive for the broad market — Value
- Price-to-book of 1.2x is a discount to asset value — Value
- ROE of 16.1% shows genuine earnings power backing the valuation — Value
Bear Case
- MACD histogram negative -- bearish momentum — Technical